Denka Co Ltd
TSE:4061
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Denka Co Ltd
Note Receivable
Denka Co Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Denka Co Ltd
TSE:4061
|
Note Receivable
¥1.1B
|
CAGR 3-Years
99%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Asahi Kasei Corp
TSE:3407
|
Note Receivable
¥10.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Kuraray Co Ltd
TSE:3405
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Toray Industries Inc
TSE:3402
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mitsui Chemicals Inc
TSE:4183
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Tosoh Corp
TSE:4042
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Denka Co Ltd
Glance View
Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.
See Also
What is Denka Co Ltd's Note Receivable?
Note Receivable
1.1B
JPY
Based on the financial report for Dec 31, 2025, Denka Co Ltd's Note Receivable amounts to 1.1B JPY.
What is Denka Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
-3%
Over the last year, the Note Receivable growth was 1 018%. The average annual Note Receivable growth rates for Denka Co Ltd have been 99% over the past three years , and -3% over the past ten years .